{"pub": "wsj", "url": "https://marketwatch.com/story/catalyst-pharmaceuticals-stock-jumps-after-stock-offering-is-pulled-2019-09-13?mod=rsswn", "downloaded_at": "2019-09-13 11:15:06.290543+00:00", "title": "Catalyst Pharmaceuticals stock jumps after stock offering is pulled", "language": "en", "text": "Shares of Catalyst Pharmaceuticals Inc. CPRX, -17.50% jumped 10% in premarket trading Friday, after the biopharmaceutical said it decided to pull its common stock offering. The company said it decided that completing an offering at current market prices \"is not in the best interest of the company and its stock holders.\" After the stock closed at a record $7.43 on Wednesday, the company said it would sell 8 million shares to the public, which would increase the shares outstanding by 7.8%. After the announcement, the stock tumbled 17.5% on Thursday. The stock has more than tripled year to date (up 219.3%) through Thursday, while the iShares Nasdaq Biotechnology ETF IBB, -0.58% has gained 8.0% and the S&P 500 SPX, +0.29% has advanced 20.1%.", "description": "Shares of Catalyst Pharmaceuticals Inc. jumped 10% in premarket trading Friday, after the biopharmaceutical said it decided to pull its common stock...", "authors": ["Tomi Kilgore", "Reporter"], "top_image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "published_at": "2019-09-13"}